A hollow fiber membrane-based liver organoid-on-a-chip model for examining drug metabolism and transport
Open accessPublished version of a preprint
The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Liver-on-a-chip models predictive for both metabolism, and blood and canalicular transport of drug candidates in humans are lacking. Here, we established a bioengineered and 3Rs-complied (animal component-free) hepatocyte-like millifluidic system based on 3D hollow fiber membranes (HFMs), recombinant human laminin 332 coating and adult human stem cell-derived organoids. Organoid fragments formed polarized and tight monolayers on HFMs with improved hepatocyte-like maturation, as compared to standard 3D organoid cultures in Matrigel from matched donors. Gene expression profiling and immunofluorescence revealed that hepatocyte-like monolayers expressed a broad panel of phase I (e.g. CYP3A4, CYP2D6, CYP2C9) and II (e.g. UGTs, SULTs) drug-metabolizing enzymes and drug transporters (e.g. MDR1, MRP3, OATP1B3). Moreover, statically cultured monolayers displayed phase I and II metabolism of a cocktail of six relevant compounds, including midazolam and 7-hydroxycoumarin. We also demonstrated the disposition of midazolam in the basal/blood-like circulation and apical/canalicular-like compartment of the millifluidic chip. Finally, we studied the bioavailability of midazolam and coumarin on-a-chip in combination with a small intestine-like system. In conclusion, we generated a proof-of-concept liver organoid-on-a-chip model for examining metabolism and transport of drugs, which can be further developed to predict pharmacokinetics’ (PK)/absorption, distribution, metabolism and excretion (ADME) profiles in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This system utilizes organoid-derived polarized epithelial monolayers cultured on recombinant human laminin-332-coated hollow fiber membranes (HFM) (Fig. 11B-D).”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [192]
In the citing paper
“This system enables precise measurement of key pharmacokinetic parameters for both parent drugs and metabolites during sustained 3-hour perfusion time, a significant improvement compared to previous perfusion times of only 10–13 min.”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [192]
In the citing paper
“Compared to conventional donor-matched organoid cultures, the system exhibits better hepatocyte-like maturation and functionality, similar to the previous model based on bile duct-on-chip HFM.”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [192]
In the citing paper
“Studies have found that the monolayers grown on differentiated HFM commonly express or enrich representative membrane proteins involved in basal uptake, efflux (Fig. 11E-G).”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [192]
In the citing paper
“This platform uniquely supports dual-directional compound tracking-quantifying initial absorption from the blood-mimicking basal side while monitoring metabolite secretion into the tubular-like apical compartment or systemic return.”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [192]
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4_9 · Cited by 12,516
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973 · cited 1×
“…can be utilized in accordance with our protocol for creating organoid-derived perfusable monolayers from other epithelial organs, for instance, breast [85], to study transepithelial transport across the highly selective blood-milk barrier to predict exposure to medication via breastfeeding [86].”
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
ComBat-seq: batch effect adjustment for RNA-seq count data
Zhang, Y., Parmigiani, G., & Johnson, W. E. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa078 · Cited by 1,566
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Hofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732 · cited 1×
“Rodent models used during preclinical development are poorly predictive for behaviors of drug candidates in humans [1], and the lack of translation results in 90% failure of those compounds during clinical development [2].”
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
Zhang, X., Chen, X., Hong, H., Hu, R., Liu, J., & Liu, C. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.014 · Cited by 680
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
Reproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511
Human Organoids: Tools for Understanding Biology and Treating Diseases
Schutgens, F., & Clevers, H. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032611 · Cited by 510
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12134 · Cited by 425
Functional Diversity of Laminins
Domogatskaya, A., Rodin, S., & Tryggvason, K. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155750 · Cited by 393
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Zhang, R.-R., Koike, H., Kimura, M., Yoshizawa, E., Enomura, M., Koike, N., Sekine, K., & Taniguchi, H. (2014) · Nature Protocols · doi:10.1038/nprot.2014.020 · Cited by 367
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337 · cited 1×
“Indeed, a performance assessment of 870 commercially manufactured (from Emulate, Inc. ) human liver-like chips confirmed that they are predictive for acute drug-induced liver injury and can be incorporated into pre-clinical development for hepatotoxicity testing [84].”
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
Marsee, A., Roos, F. J. M., Verstegen, M. M. A., Marsee, A., Roos, F., Verstegen, M., Clevers, H., Vallier, L., Takebe, T., Huch, M., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.005 · Cited by 310 · cited 1×
“Human stem cell-derived 3D organoids from the healthy adult liver, so-called intrahepatic cholangio-cyte organoids (ICOs) [21], are a robust cell source for establishing liver-on-a-chip systems.”
Self-citationCyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice
Ni, H., Wang, Y., Yao, K., Wang, L., Huang, J., Xiao, Y., Chen, H., Liu, B., Yang, C. Y., & Zhao, J. (2024) · Nature Communications · doi:10.1038/s41467-023-43650-z · Cited by 281
Membrane transporters in drug development and as determinants of precision medicine
Galetin, A., Brouwer, K. L. R., Tweedie, D., Yoshida, K., Sjöstedt, N., Aleksunes, L., Chu, X., Evers, R., Hafey, M. J., Lai, Y., et al. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00877-1 · Cited by 238
Tsamandouras, N., Chen, W. L. K., Edington, C. D., Stokes, C. L., Griffith, L. G., & Cirit, M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0122-4 · Cited by 222 · cited 1×
“…cultured organoid-based small intestine-like Transwell system [40] to study the first-pass effect and bioavailability of midazolam and coumarin upon oral administration (apical/luminal-like compartment) (figure 6(A)), similar to previous dual-organ system studies using different compounds [59–62].”
Maschmeyer, I., Hasenberg, T., Jaenicke, A., Lindner, M., Lorenz, A. K., Zech, J., Garbe, L.-A., Sonntag, F., Hayden, P., Ayehunie, S., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.002 · Cited by 218
Animal versus human oral drug bioavailability: Do they correlate?
Musther, H., Olivares-Morales, A., Hatley, O. J. D., Liu, B., & Rostami Hodjegan, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.018 · Cited by 211 · cited 1×
“The lack of predictiveness for pharmacokin-etics’ (PK) parameters in humans, i.e. absorption, distribution, metabolism and excretion (ADME), is the second major biological reason for high attrition rates of drug candidates in phase I of clinical development, after safety [1, 4].”
Takayama, K., Morisaki, Y., Kuno, S., Nagamoto, Y., Harada, K., Furukawa, N., Ohtaka, M., Nishimura, K., Imagawa, K., Sakurai, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413481111 · Cited by 193
Lorenzini, S., Bird, T. G., Boulter, L., Bellamy, C., Samuel, K., Aucott, R., Clayton, E., Andreone, P., Bernardi, M., Golding, M., et al. (2010) · Gut · doi:10.1136/gut.2009.182345 · Cited by 190
Integrating organoids and organ-on-a-chip devices
Zhao, Y., Landau, S., Okhovatian, S., Liu, C., Lu, R. X. Z., Lai, B. F. L., Wu, Q., Kieda, J., Cheung, K., Rajasekar, S., et al. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00207-z · Cited by 185
Paris, J., & Henderson, N. C. (2022) · Hepatology · doi:10.1002/hep.32408 · Cited by 168
Saravanakumar, A., Sadighi, A., Ryu, R. J., & Akhlaghi, F. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00750-8 · Cited by 165
A Chemically Defined Hydrogel for Human Liver Organoid Culture
Ye, S., Boeter, J. W. B., Mihajlovic, M., van Steenbeek, F. G., van Wolferen, M. E., Oosterhoff, L. A., Marsee, A., Caiazzo, M., van der Laan, L. J. W., Penning, L. C., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000893 · Cited by 164
Self-citationRecombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes
Cameron, K., Tan, R., Schmidt-Heck, W., Campos, G., Lyall, M. J., Wang, Y., Lucendo-Villarin, B., Szkolnicka, D., Bates, N., Kimber, S. J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.016 · Cited by 149
Zhou, Y., & Lauschke, V. M. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00288-2 · Cited by 144
Mechanism of cytochrome P450-3A inhibition by ketoconazole
Greenblatt, D. J., Zhao, Y., Venkatakrishnan, K., Duan, S. X., Harmatz, J. S., Parent, S. J., Court, M. H., & Moltke, L. L. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01202.x · Cited by 130
Challenges and Opportunities in the Design of Liver-on-Chip Microdevices
Ehrlich, A., Duche, D., Ouedraogo, G., & Nahmias, Y. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-060418-052305 · Cited by 125
Jansen, J., Napoli, I. E. D., Fedecostante, M., Schophuizen, C. M. S., Chevtchik, N. V., Wilmer, M. J. G., van Asbeck, A. H., Croes, H. J. E., Pertijs, J. C. L. M., Wetzels, J. F. M., et al. (2015) · Scientific Reports · doi:10.1038/srep16702 · Cited by 122
Self-citationStem cell-derived polarized hepatocytes
Thi, V. L. D., Wu, X., Belote, R. L., Andréo, U., Takacs, C. N., Fernandez, J., Vale-Silva, L. A., Prallet, S., Decker, C. C., Fu, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15337-2 · Cited by 112
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
Järvinen, E., Deng, F., Kiander, W., Sinokki, A., Kidron, H., & Sjöstedt, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.802539 · Cited by 111
Kratochwil, N. A., Meille, C., Fowler, S., Klammers, F., Ekiciler, A., Molitor, B., Simon, S., Walter, I., McGinnis, C., Walther, J., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0019-7 · Cited by 109
Fowler, S., Chen, W. L. K., Duignan, D. B., Gupta, A., Hariparsad, N., Kenny, J. R., Lai, W. G., Liras, J., Phillips, J. A., & Gan, J. (2020) · Lab on a Chip · doi:10.1039/c9lc00857h · Cited by 109
Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells
Chen, C., Soto-Gutierrez, A., Baptista, P. M., & Spee, B. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.066 · Cited by 107
Self-citationRemodelling of extracellular matrix is a requirement for the hepatic progenitor cell response
Kallis, Y. N., Robson, A. J., Fallowfield, J. A., Thomas, H. C., Alison, M. R., Wright, N. A., Goldin, R. D., Iredale, J. P., & Forbes, S. J. (2011) · Gut · doi:10.1136/gut.2010.224436 · Cited by 106
Directed Stem Cell Differentiation: The Role of Physical Forces
Clause, K. C., Liu, L., & Tobita, K. (2010) · Cell Communication & Adhesion · doi:10.3109/15419061.2010.492535 · Cited by 103
Spaggiari, D., Geiser, L., Daali, Y., & Rudaz, S. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.03.018 · Cited by 100
Rubiano, A., Indapurkar, A., Yokosawa, R., Miedzik, A., Rosenzweig, B., Arefin, A., Moulin, C. M., Dame, K., Hartman, N., Volpe, D. A., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.12969 · Cited by 96
Towards in vitro models for reducing or replacing the use of animals in drug testing
Stresser, D. M., Kopec, A. K., Hewitt, P., Hardwick, R. N., Van Vleet, T. R., Mahalingaiah, P. K. S., O’Connell, D., Jenkins, G. J., David, R., Graham, J., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01154-7 · Cited by 94 · cited 3×
“These components are undefined, which results in experimental variability, poor reproducibility and the lack of standardization of liver-on-a-chip systems, potentially blocking their approval by regulatory agencies [3].”
InfluentialProt, J. M., Maciel, L., Bricks, T., Merlier, F., Cotton, J., Paullier, P., Bois, F. Y., & Leclerc, E. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25232 · Cited by 90
Kanninen, L. K., Harjumäki, R., Peltoniemi, P., Bogacheva, M. S., Salmi, T., Porola, P., Niklander, J., Smutný, T., Urtti, A. O., Yliperttula, M. L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.054 · Cited by 89
Milani, N., Parrott, N. J., Franyuti, D. O., Godoy, P., Galetin, A., Gertz, M., & Fowler, S. M. (2022) · Lab on a Chip · doi:10.1039/d2lc00276k · Cited by 78
Standardizing designed and emergent quantitative features in microphysiological systems
Nahon, D. M., Moerkens, R., Aydoğmuş, H., Lendemeijer, B., Martínez-Silgado, A., Stein, J. M., Dostanić, M., Frimat, J., Gontan, C., de Graaf, M. N. S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01236-0 · Cited by 71
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development
Fukami, T., Yokoi, T., & Nakajima, M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-105907 · Cited by 68
Docci, L., Milani, N., Ramp, T., Romeo, A. A., Godoy, P., Franyuti, D. O., Krähenbühl, S., Gertz, M., Galetin, A., Parrott, N., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc01161h · Cited by 66
van Genderen, A. M., Jansen, K., Kristen, M., van Duijn, J., Li, Y., Schuurmans, C. C. L., Malda, J., Vermonden, T., Jansen, J., Masereeuw, R., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.617364 · Cited by 63
Self-citationCharacterization of 1′-Hydroxymidazolam Glucuronidation in Human Liver Microsomes
Zhu, B. Y., Bush, D. R., Doss, G. A., Vincent, S. H., Franklin, R. B., & Xu, S. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017962 · Cited by 55
Bessone, F., Hernandez, N., Tagle, M., Arrese, M., Parana, R., Méndez-Sánchez, N., Ridruejo, E., Mendizabal, M., Dagher, L., Contreras, F., et al. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100321 · Cited by 54
Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research
Yamashita, T., Inui, T., Yokota, J., Kawakami, K., Morinaga, G., Takatani, M., Hirayama, D., Nomoto, R., Ito, K., Cui, Y., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.005 · Cited by 54
Isvoran, A., Peng, Y., Ceauranu, S., Schmidt, L., Nicot, A. B., & Miteva, M. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103349 · Cited by 53
Keuper-Navis, M., Walles, M., Poller, B., Myszczyszyn, A., van der Made, T. K., Donkers, J., Eslami Amirabadi, H., Wilmer, M. J., Aan, S., Spee, B., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106853 · Cited by 52
Self-citationAmirabadi, H. E., Donkers, J. M., Wierenga, E., Ingenhut, B. L. J., Pieters, L., Stevens, L. J., Donkers, T., Westerhout, J., Masereeuw, R., Bobeldijk‐Pastorova, I., et al. (2021) · Lab on a Chip · doi:10.1039/d1lc00669j · Cited by 51
Self-citationNauwelaerts, N., Deferm, N., Smits, A., Bernardini, C., Lammens, B., Gandia, P., Panchaud, A., Nordeng, H., Bacci, M. L., Forni, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111038 · Cited by 46
Hendriks, D. F. G., Artegiani, B., Margaritis, T., Zoutendijk, I., Lopes, S. M. C. D. S., & Clevers, H. C. (2024) · Nature Communications · doi:10.1038/s41467-024-48550-4 · Cited by 45
Bioengineered bile ducts recapitulate key cholangiocyte functions
Chen, C., Jochems, P. G. M., Salz, L., Schneeberger, K., Penning, L. C., van de Graaf, S. F. J., Beuers, U., Clevers, H., Geijsen, N., Masereeuw, R., et al. (2018) · Biofabrication · doi:10.1088/1758-5090/aac8fd · Cited by 42
Self-citationUmehara, K., Cantrill, C., Wittwer, M., Lenarda, E. D., Klammers, F., Ekiciler, A., Parrott, N. J., Fowler, S. M., & Ullah, M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000133 · Cited by 42
Bricks, T., Hamon, J., Fleury, M. J., Jellali, R., Merlier, F., Herpe, Y. E., Seyer, A., Regimbeau, J., Bois, F., & Leclerc, E. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1940 · Cited by 41
Polymerizing laminins in development, health, and disease
Yurchenco, P. D., & Kulczyk, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107429 · Cited by 38
Rajan, S. A. P., Sherfey, J. S., Ohri, S., Nichols, L., Smith, J. T., Parekh, P., Kadar, E. P., Clark, F., George, B. T., Gregory, L., et al. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00870-x · Cited by 37
Donato, M. T., Hallifax, D., Picazo, L., Castell, J. V., Houston, J. B., Gómez‐Lechón, M. J., & Lahoz, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033605 · Cited by 36
Wake, K., & Sato, T. (2015) · The Anatomical Record · doi:10.1002/ar.23263 · Cited by 35
Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing
Bouwmeester, M., Tao, Y., Proença, S., van Steenbeek, F. G., Samsom, R., Nijmeijer, S. M., Sinnige, T. L., van der Laan, L. J. W., Legler, J., Schneeberger, K., et al. (2023) · Molecules · doi:10.3390/molecules28020621 · Cited by 35
Self-citationLiver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 35
DigiLoCS: A leap forward in predictive organ-on-chip simulations
Aravindakshan, M. R., Mandal, C., Pothen, A., Schaller, S., & Maaß, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314083 · Cited by 35
Cox, B., Barton, P., Class, R., Coxhead, H., Delatour, C., Gillent, E., Henshall, J., Isin, E. M., King, L. M., & Valentin, J. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100054 · Cited by 34
Jochems, P. G. M., van Bergenhenegouwen, J., van Genderen, A. M., Eis, S., Versprille, L. J. F. W., Wichers, H. J., Jeurink, P. V., Garssen, J., & Masereeuw, R. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.04.019 · Cited by 33
Self-citationHuman Cholangiocytes Form a Polarized and Functional Bile Duct on Hollow Fiber Membranes
Wang, Z., Faria, J., van der Laan, L. J. W., Penning, L. C., Masereeuw, R., & Spee, B. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.868857 · Cited by 32
Self-citationExtracellular matrix microarrays to study inductive signaling for endoderm specification
Malta, D. F. B., Reticker-Flynn, N. E., da Silva, C. L., Cabral, J. M. S., Fleming, H. E., Zaret, K. S., Bhatia, S. N., & Underhill, G. H. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.014 · Cited by 31
Hollow fiber culture accelerates differentiation of Caco-2 cells
Deng, X., Zhang, G., Shen, C., Yin, J. B., & Meng, Q. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4975-x · Cited by 30
Watanabe, M., Zemack, H., Johansson, H., Hagbard, L., Jorns, C., Li, M., & Ellis, E. C. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161383 · Cited by 20
Cancer Hazard Identification Integrating Human Variability: The Case of Coumarin
Hsieh, C., Sun, M., Osborne, G., Ricker, K., Tsai, F. C., Li, K., Tomar, R. S., Phuong, J., Schmitz, R., & Sandy, M. S. (2019) · International Journal of Toxicology · doi:10.1177/1091581819884544 · Cited by 18
Ong, J., Serra, M. P., Segal, J. M., Cujba, A.-M., Ng, S. S., Butler, R., Millar, V., Hatch, S. B., Zimri, S., Koike, H., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.025 · Cited by 16
Caetano-Pinto, P., Nordell, P., Nieskens, T., Haughan, K., Fenner, K. S., & Stahl, S. H. (2022) · ALTEX · doi:10.14573/altex.2204011 · Cited by 13
Chemically Defined Organoid Culture System for Cholangiocyte Differentiation
Wang, Z., Ye, S., van der Laan, L. J. W., Schneeberger, K., Masereeuw, R., & Spee, B. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401511 · Cited by 13
Self-citationStreekstra, E. J., Keuper-Navis, M., van den Heuvel, J. J. M. W., van den Broek, P., Stommel, M. W. J., Bervoets, S., O'Gorman, L., Greupink, R., Rüssel, F. G. M., van de Steeg, E., et al. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106877 · Cited by 13
Self-citationIntestinal Cells-on-Chip for Permeability Studies
Keuper-Navis, M., Amirabadi, H. E., Donkers, J. M., Walles, M., Poller, B., Heming, B., Pieters, L., de Wagenaar, B., Myszczyszyn, A., Sinnige, T. L., et al. (2024) · Micromachines · doi:10.3390/mi15121464 · Cited by 8
Self-citationJuvonen, R. O., Heikkinen, A. T., Kärkkäinen, O. K., Jehangir, R., Huuskonen, J., Troberg, J., Raunio, H., Pentikäinen, O. T., & Finel, M. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105118 · Cited by 7
Wu, H., Yang, A., Stelloo, S., Roos, F. J. M., Morsche, R. H. M. T., Verkerk, A. H., Velez, M. V. L., Wingens, L., de Wilt, J. H. W., Sauerwein, R. W., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.050883 · Cited by 7
Yamada, M., Okada, H., Kikkawa, Y., Miyajima, A., & Itoh, T. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.104 · Cited by 6
Cited by
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 129
Organ-on-a-Chip: A Roadmap for Translational Research in Human and Veterinary Medicine
Surina, S., Chmielewska, A., Pratscher, B., Freund, P., Rodríguez-Rojas, A., & Burgener, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110753 · Cited by 24
Functional material probes and advanced technologies in organ-on-a-chip characterization
Wang, Y., Chang, X. M., Deng, S., Tang, S., & Chen, P. (2025) · Theranostics · doi:10.7150/thno.122552 · Cited by 22
Hong, C.-E., & Lyu, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101258 · Cited by 17
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
Metadata
- Authors
- Myszczyszyn, A., Muench, A., Lehmann, V., Sinnige, T., van Steenbeek, F. G., Bouwmeester, M., Samsom, R.-A., Keuper-Navis, M., van der Made, T. K., Kogan, D., Braem, S., van der Laan, L. J. W., Eslami Amirabadi, H., van de Steeg, E., Masereeuw, R., & Spee, B.
- Affiliations
- Utrecht University (NL)
- Netherlands Organisation for Applied Scientific Research (NL)
- ORCID
- Venue
- Biofabrication
- Publisher
- IOP Publishing
- Published
- 2025-04-01
- Volume
- 17
- Issue
- 2
- Pages
- 025035
- ISSN
- 1758-5082 (ISSN-L)
- 1758-5090
- OpenAlex
- W4408701756
- Cited by
- 14
- References
- 88
- Citations by year
- 2026: 9 · 2025: 5
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- iopscience.iop.org/info/page/text-and-data-mining (tdm)
- Locations
- Biofabrication (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- TNO Repository (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
- Funders
- Health~Holland (LSHM20045-SGF)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- liver organoids, hollow fiber membranes, organ-on-a-chip, drug metabolism, drug transport, stem cell-derived organoids, midazolam, umbelliferone, drug-metabolizing enzymes, drug transporters, canalicular transport, bioavailability, ADME prediction
- MeSH terms
- Biological Transport, Pharmaceutical Preparations, Humans, Liver, Membranes, Artificial, Midazolam, Models, Biological, Organoids, Hepatocytes, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.